Key result
COVID-19 in pregnancy is linked to higher adverse cardiovascular risk versus nonpregnant women.
Why the study?
Current statements on COVID-19 cardiac complications omit pregnancy-specific conditions that mimic them, and pregnant patients are frequently excluded from research studies despite facing higher risks.
Pregnant women with COVID-19 face increased risks of severe complications, and their cardiovascular management requires special consideration due to overlapping pregnancy-related conditions.
May warrant enhanced cardiovascular monitoring in pregnant women with COVID-19; leaves open optimal preventive strategies pending prospective data.
Cardiovascular complications are frequently present in coronavirus-2019 (COVID-19) infection. These include microvascular and macrovascular thrombotic complications such as arterial and venous thromboembolism, myocardial injury or inflammation resulting in infarction, heart failure, and arrhythmias. Data suggest increased risk of adverse outcomes in pregnant compared with nonpregnant women of reproductive age with COVID-19 infection, including need for intensive care unit admission, mechanical ventilation, and extracorporeal membrane oxygenation utilization. Current statements addressing COVID-19-associated cardiac complications do not include pregnancy complications that may mimic COVID-19 complications such as peripartum cardiomyopathy, spontaneous coronary artery dissection, and preeclampsia. Unique to pregnancy, COVID-19 complications can result in preterm delivery and modify management of the pregnancy. Moreover, pregnancy has often been an exclusion criterion for enrollment in research studies. In this review, we summarize what is known about pregnancy-associated COVID-19 cardiovascular complications.
No takes yet. Share an insight, caveat, or question.
Briller et al. (2022) conducted a review in Pregnancy-associated COVID-19 cardiovascular complications. Pregnancy-associated COVID-19 infection vs. Nonpregnant women of reproductive age with COVID-19 was evaluated. This review highlights that pregnant women with COVID-19 have an increased risk of adverse cardiovascular outcomes compared with nonpregnant women of reproductive age.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: